𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients

✍ Scribed by Yoshihiro Sato; Yoshiaki Honda; Jun Iwamoto; Tomohiro Kanoko; Kei Satoh

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
76 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The above article, published online on 19 August 2005 in Wiley Online Library (http://wileyonlinelibrary.com) has been retracted by agreement between the authors, the Journal Editor‐in‐Chief, Jose A. Obeso, MD, PhD and John Wiley & Sons Inc. The Retraction has been agreed due to extensive duplication of work previously published by the same authors and concerns with authorship and data integrity. Reference Sato, Y. , Honda, Y. , Iwamoto, J. , Kanoko, T. and Satoh, K. (2005), Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. Mov. Disord., 20: 1598‐1603. doi:10.1002/mds.20658

πŸ“œ SIMILAR VOLUMES

Abnormal visual activation in Parkinson'
Abnormal visual activation in Parkinson's disease patients
✍ Ellison Fernando Cardoso; Felipe Fregni; Fernanda Martins Maia; Luciano M. Melo; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

## Abstract Among nonmotor symptoms observed in Parkinson's disease (PD) dysfunction in the visual system, including hallucinations, has a significant impact in their quality of life. To further explore the visual system in PD patients we designed two fMRI experiments comparing 18 healthy volunteer

Risk factors for metabolic bone disease
Risk factors for metabolic bone disease in Crohn's disease patients
✍ MarΓ­lia Cravo; Catarina Sousa Guerreiro; Paula Moura dos Santos; Miguel Brito; P πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Background: The aim was to evaluate the presence of metabolic bone disease (MBD) in patients with Crohn's disease (CD) and to identify potential etiologic factors. ## Methods: The case-control study included 99 patients with CD and 56 controls with a similar age and gender distribution. Both

Meta-analysis of heart valve abnormaliti
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists
✍ Gregor Simonis; Joerg T. Fuhrmann; Ruth H. Strasser πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 184 KB πŸ‘ 1 views

## Abstract Valvular heart disease in patients being treated with ergot‐derivative dopamine agonists (Ergot‐DA) for Parkinson's disease has been reported to occur as a consequence of serotonine receptor stimulation. Goal of this analysis was to estimate the incidence of those changes from recently

Risk factors for Parkinson's disease and
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id